Home
>
National Drug Code (NDC)
>
Clindamycin Hydrochloride
Clindamycin Hydrochloride - 0093-5256-01 - (Clindamycin Hydrochloride)
Drug Information of Clindamycin Hydrochloride
| Product NDC: | 0093-5256 |
| Proprietary Name: | Clindamycin Hydrochloride |
| Non Proprietary Name: | Clindamycin Hydrochloride |
| Active Ingredient(s): | 300 mg/1 & nbsp; Clindamycin Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clindamycin Hydrochloride
| Product NDC: | 0093-5256 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA063029 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050809 |
Package Information of Clindamycin Hydrochloride
| Package NDC: | 0093-5256-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (0093-5256-01) |
NDC Information of Clindamycin Hydrochloride
| NDC Code | 0093-5256-01 |
| Proprietary Name | Clindamycin Hydrochloride |
| Package Description | 100 CAPSULE in 1 BOTTLE (0093-5256-01) |
| Product NDC | 0093-5256 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clindamycin Hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20050809 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | CLINDAMYCIN HYDROCHLORIDE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
